Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease

JR Hurst, GC Donaldson, WR Perera… - American journal of …, 2006 - atsjournals.org
Impact: This study explores the use of measuring plasma biomarkers at exacerbation of
chronic obstructive pulmonary disease (COPD), providing insight into the underlying …

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease

M Thomsen, TS Ingebrigtsen, JL Marott, M Dahl… - Jama, 2013 - jamanetwork.com
Importance Exacerbations of respiratory symptoms in chronic obstructive pulmonary disease
(COPD) have profound and long-lasting adverse effects on patients. Objective To test the …

[HTML][HTML] A systematic review of diagnostic biomarkers of COPD exacerbation

YWR Chen, JM Leung, DD Sin - PloS one, 2016 - journals.plos.org
The aims of this systematic review were to determine which blood-based molecules have
been evaluated as possible biomarkers to diagnose chronic obstructive pulmonary disease …

Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge

A Koutsokera, D Stolz, S Loukides, K Kostikas - Chest, 2012 - Elsevier
Background Exacerbations of COPD (ECOPD) remain a major cause of mortality and
morbidity. Despite advances in the understanding of their pathophysiology, their assessment …

[HTML][HTML] Serum biomarkers in patients with stable and acute exacerbation of chronic obstructive pulmonary disease: a comparative study

F Şahin, AF Koşar, AF Aslan, B Yiğitbaş… - Journal of medical …, 2019 - ncbi.nlm.nih.gov
Background Mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR) and platelet-
to-lymphocyte ratio (PLR) have all been investigated as novel inflammatory markers of …

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

M Dahl, J Vestbo, P Lange, SE Bojesen… - American journal of …, 2007 - atsjournals.org
Rationale: Patients with chronic obstructive pulmonary disease (COPD) have an ongoing
systemic inflammation, which can be assessed by measuring serum C-reactive protein …

Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers

M Bafadhel, S McKenna, S Terry, V Mistry… - American journal of …, 2011 - atsjournals.org
Rationale: Exacerbations of chronic obstructive pulmonary disease (COPD) are
heterogeneous with respect to inflammation and etiology. Objectives: Investigate biomarker …

Alterations of the neutrophil–lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients

M Taylan, M Demir, H Kaya… - The clinical …, 2017 - Wiley Online Library
Objectives We aimed to investigate the importance of neutrophil–lymphocyte ratio (NLR) in
patients with chronic obstructive pulmonary disease (COPD) for identifying the severity of …

Raised CRP levels mark metabolic and functional impairment in advanced COPD

R Broekhuizen, EFM Wouters, EC Creutzberg… - Thorax, 2006 - thorax.bmj.com
Background: C-reactive protein (CRP) is often used as a clinical marker of acute systemic
inflammation. Since low grade inflammation is evident in chronic diseases such as chronic …

[HTML][HTML] Pulmonary biomarkers in COPD exacerbations: a systematic review

A Koutsokera, K Kostikas, LP Nicod, JW Fitting - Respiratory research, 2013 - Springer
Exacerbations of COPD (ECOPD) represent a major burden for patients and health care
systems. Innovative sampling techniques have led to the identification of several pulmonary …